Month: March 2023

Trondheim, 30 March 2023: NORBIT today announces that it has published its Annual Report for 2022, which also includes the Sustainability Report and the Corporate Governance Report, which the board of directors approved on 29 March 2023. “Our ability to develop and grow continued to be demonstrated in 2022. We delivered close to 50 per cent growth in revenues and improved profitability, driven by strong performance across all our business segments. We are on-track to reach our ambition of delivering NOK 1.5 billion in revenues and an EBITDA margin of 25 per cent in 2024. Since 2010, revenues have on average grown by 31 per cent annually and we have improved our profitability, laying the foundation for long-term value creation,” says Per Jørgen Weisethaunet, CEO of NORBIT. The report is attached to this notice and is also available...

LUXEMBOURG, March 30, 2023 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced today that its Brazilian subsidiary Confab Industrial S.A., together with its affiliates Ternium Investments and Ternium Argentina, all of which compose the T/T group within Usiminas control group, have entered into a share purchase agreement to acquire from Nippon Steel Corporation, Mitsubishi and MetalOne (the “NSC group”), pro rata to their current participations in the T/T group, 68.7 million ordinary shares of Usinas Siderúrgicas de Minas Gerais S.A. – USIMINAS (“Usiminas”) at a price of BRL10 per ordinary share. Pursuant to the transaction, Tenaris would pay BRL 110 million (approximately USD21 million) in cash for 11.0 million ordinary shares, increasing its participation in the Usiminas control group to 9.8%. The...

REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $30.00 per share. The gross proceeds to Biomea from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $150.0 million. In addition, Biomea has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price less underwriting discounts and...

Revenues increase 26% on the strength of waste treatment contracts with multinational corporate clientsSingapore & New York, NY, March 29, 2023 (GLOBE NEWSWIRE) — Environmental Solutions Group Holdings Limited (“ESGL”) today announced the filing of an amendment to the registration statement on Form F-4 (the “Registration Statement”) filed by ESGL Holdings Limited (“PubCo”) with the U.S. Securities and Exchange Commission (“SEC”), which includes the financial results of ESGL for the fiscal years ended December 31, 2022 and 2021. ESGL, through its operating entity in Singapore, Environmental Solutions (Asia) Pte. Ltd. (“ESA”), is a sustainable waste solutions provider whose mission is to recycle industrial waste into circular products using innovative technologies and renewable energy. On November 30, 2022, Genesis Unicorn...

DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 30, 2023, to provide a corporate update and discuss the Company’s financial results for the fourth quarter and full year ended December 31, 2022. A live audio webcast of the call be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event. Participants may register for the conference call here and are advised to do so at least 10 minutes prior to joining the call. About Avadel Pharmaceuticals plcAvadel Pharmaceuticals plc...

DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (“Avadel”) (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today the pricing of an underwritten public offering of 10,000,001 of its ordinary shares, nominal value $0.01 per share (“Ordinary Shares”) in the form of American Depositary Shares (“ADSs”) and of 4,705,882 Series B Non-Voting Convertible Preferred Shares, convertible into Ordinary Shares on a one-for-one basis (the “Preferred Shares,” together with the ADSs, the “Shares”). Each ADS represents the right to receive one Ordinary Share. All of the Shares are being offered by Avadel. The public offering price of each ADS is $8.50 and the public offering price of each Preferred Share is $8.50. In connection with the public offering, Avadel...

Short Delay Required to File Form 10-K NEWPORT BEACH, Calif. and LEHI, Utah, March 29, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales-enablement applications, including MARKET.live, its livestream social shopping platform, announces today that a short delay is required to complete the filing of its Form 10-K. The delay is necessary to allow the Company to adequately assess certain subsequent events and complete the audit and finalization of its annual report on Form 10-K. The Company will announce the new filing date and associated earnings call as soon as it is established, which is expected to be within the extension period afforded by Form 12b-25. About VERB Verb Technology Company, Inc. (Nasdaq: VERB), the market...

ONTARIO, Calif., March 29, 2023 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF), the holding company for Citizens Business Bank, was ranked by S&P Global Market Intelligence as the third best-performing public bank with assets greater than $10 billion in the United States for 2022. S&P Global Market Intelligence recently released its annual rankings of the best-performing U.S. public banks with assets exceeding $10 billion. Ontario, Calif.-based CVB Financial Corp. was ranked third overall and was the only bank in the analysis of the top 50 U.S. public banks to score better than the industry median for all seven metrics that were considered in the ranking. “It is a great honor to be recognized by S&P Global Market Intelligence as one of the top three banks in the country,” said David A. Brager, President and...